Cart
sales@molnova.com
XY028-133
CAS No. 2229974-73-4
XY028-133( —— )
Catalog No. M33174 CAS No. 2229974-73-4
XY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 546 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 493 | In Stock |
|
| 25MG | 847 | In Stock |
|
| 50MG | 1460 | In Stock |
|
| 100MG | 2539 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXY028-133
-
NoteResearch use only, not for human use.
-
Brief DescriptionXY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
-
DescriptionXY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity, which consists of ligands for von Hippel-Lindau and CDK.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPROTACs | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2229974-73-4
-
Formula Weight1002.23
-
Molecular FormulaC53H67N11O7S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (49.89 mM; Ultrasonic )
-
SMILESCC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCN(CC3)C(=O)CCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(cc3)-c3scnc3C)C(C)(C)C)nc2n(C2CCCC2)c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. JIN, Jian， et al. COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER. Patent. US2017/065027.
molnova catalog
related products
-
Madecassoside
Madecassoside is a pentacyclic triterpene extracted from Centella asitica (L.) with anti-inflammatory, anti-oxidative and anti-aging activities.
-
3,6-Disinapoylsucros...
3,6-Disinapoylsucrose
-
Fondaparinux sodium
Fondaparinux Sodium is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity.
